UniProt ID | TF2B_HUMAN | |
---|---|---|
UniProt AC | Q00403 | |
Protein Name | Transcription initiation factor IIB | |
Gene Name | GTF2B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 316 | |
Subcellular Localization | Nucleus. | |
Protein Description | General factor that plays a major role in the activation of eukaryotic genes transcribed by RNA polymerase II.. | |
Protein Sequence | MASTSRLDALPRVTCPNHPDAILVEDYRAGDMICPECGLVVGDRVIDVGSEWRTFSNDKATKDPSRVGDSQNPLLSDGDLSTMIGKGTGAASFDEFGNSKYQNRRTMSSSDRAMMNAFKEITTMADRINLPRNIVDRTNNLFKQVYEQKSLKGRANDAIASACLYIACRQEGVPRTFKEICAVSRISKKEIGRCFKLILKALETSVDLITTGDFMSRFCSNLCLPKQVQMAATHIARKAVELDLVPGRSPISVAAAAIYMASQASAEKRTQKEIGDIAGVADVTIRQSYRLIYPRAPDLFPTDFKFDTPVDKLPQL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MASTSRLDAL -----CCCCCCCCCC | 26.14 | 23186163 | |
4 | Phosphorylation | ----MASTSRLDALP ----CCCCCCCCCCC | 14.34 | 23186163 | |
5 | Phosphorylation | ---MASTSRLDALPR ---CCCCCCCCCCCC | 28.49 | 23186163 | |
27 | Phosphorylation | DAILVEDYRAGDMIC CEEEECCCCCCCEEC | 6.72 | 21214269 | |
32 | Sulfoxidation | EDYRAGDMICPECGL CCCCCCCEECCCCCC | 3.12 | 21406390 | |
55 | Ubiquitination | VGSEWRTFSNDKATK CCCCCEECCCCCCCC | 4.88 | 22817900 | |
59 | Ubiquitination | WRTFSNDKATKDPSR CEECCCCCCCCCHHH | 63.31 | 29967540 | |
65 | Phosphorylation | DKATKDPSRVGDSQN CCCCCCHHHCCCCCC | 50.13 | 23090842 | |
69 | Ubiquitination | KDPSRVGDSQNPLLS CCHHHCCCCCCCCCC | 44.16 | 21890473 | |
70 | Phosphorylation | DPSRVGDSQNPLLSD CHHHCCCCCCCCCCC | 26.40 | 21712546 | |
76 | Phosphorylation | DSQNPLLSDGDLSTM CCCCCCCCCCCHHHH | 47.43 | 25159151 | |
81 | Phosphorylation | LLSDGDLSTMIGKGT CCCCCCHHHHCCCCC | 22.22 | 28464451 | |
82 | Phosphorylation | LSDGDLSTMIGKGTG CCCCCHHHHCCCCCC | 21.80 | 29116813 | |
83 | Sulfoxidation | SDGDLSTMIGKGTGA CCCCHHHHCCCCCCC | 3.23 | 21406390 | |
86 | Ubiquitination | DLSTMIGKGTGAASF CHHHHCCCCCCCCCH | 42.23 | 21906983 | |
88 | Ubiquitination | STMIGKGTGAASFDE HHHCCCCCCCCCHHH | 27.42 | 23000965 | |
88 | Phosphorylation | STMIGKGTGAASFDE HHHCCCCCCCCCHHH | 27.42 | 27251275 | |
92 | Phosphorylation | GKGTGAASFDEFGNS CCCCCCCCHHHCCCC | 32.47 | 25159151 | |
100 | Ubiquitination | FDEFGNSKYQNRRTM HHHCCCCHHCCCCCC | 55.65 | 23000965 | |
100 | Acetylation | FDEFGNSKYQNRRTM HHHCCCCHHCCCCCC | 55.65 | 25953088 | |
109 | Phosphorylation | QNRRTMSSSDRAMMN CCCCCCCHHHHHHHH | 25.99 | 22210691 | |
110 | Phosphorylation | NRRTMSSSDRAMMNA CCCCCCHHHHHHHHH | 24.65 | 22210691 | |
112 | Ubiquitination | RTMSSSDRAMMNAFK CCCCHHHHHHHHHHH | 26.74 | 21890473 | |
119 | Ubiquitination | RAMMNAFKEITTMAD HHHHHHHHHHHHHHH | 45.88 | 23000965 | |
123 | Phosphorylation | NAFKEITTMADRINL HHHHHHHHHHHHCCC | 18.94 | - | |
127 | Methylation | EITTMADRINLPRNI HHHHHHHHCCCCHHH | 15.34 | - | |
143 | Ubiquitination | DRTNNLFKQVYEQKS HHHHHHHHHHHHHHC | 41.86 | 21906983 | |
147 | Ubiquitination | NLFKQVYEQKSLKGR HHHHHHHHHHCCCCC | 53.31 | 23000965 | |
149 | Ubiquitination | FKQVYEQKSLKGRAN HHHHHHHHCCCCCHH | 45.90 | 33845483 | |
178 | Ubiquitination | EGVPRTFKEICAVSR CCCCCCHHHHHHHHC | 45.62 | 23000965 | |
178 | Acetylation | EGVPRTFKEICAVSR CCCCCCHHHHHHHHC | 45.62 | 25953088 | |
196 | Acetylation | KEIGRCFKLILKALE HHHHHHHHHHHHHHH | 37.94 | 25953088 | |
238 | Ubiquitination | AATHIARKAVELDLV HHHHHHHHHHHCCCC | 48.00 | 12931194 | |
238 | Acetylation | AATHIARKAVELDLV HHHHHHHHHHHCCCC | 48.00 | 12931194 | |
249 | Phosphorylation | LDLVPGRSPISVAAA CCCCCCCCHHHHHHH | 32.28 | 25159151 | |
252 | Phosphorylation | VPGRSPISVAAAAIY CCCCCHHHHHHHHHH | 14.75 | 25627689 | |
270 | Phosphorylation | QASAEKRTQKEIGDI HHHHHHHHHHHHHHH | 55.87 | - | |
272 | Ubiquitination | SAEKRTQKEIGDIAG HHHHHHHHHHHHHHC | 51.16 | - | |
274 | Ubiquitination | EKRTQKEIGDIAGVA HHHHHHHHHHHHCCC | 8.49 | 22817900 | |
281 | Ubiquitination | IGDIAGVADVTIRQS HHHHHCCCCEEEEEE | 12.49 | 24816145 | |
284 | Phosphorylation | IAGVADVTIRQSYRL HHCCCCEEEEEEEEE | 15.81 | - | |
293 | Phosphorylation | RQSYRLIYPRAPDLF EEEEEEECCCCCCCC | 7.40 | 22817900 | |
305 | Ubiquitination | DLFPTDFKFDTPVDK CCCCCCCCCCCCHHH | 45.18 | 22817900 | |
312 | Ubiquitination | KFDTPVDKLPQL--- CCCCCHHHCCCC--- | 63.40 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TF2B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
238 | K | Acetylation |
| 12931194 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TF2B_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND MASSSPECTROMETRY. |